Healthcare Industry News: diabetes
News Release - April 21, 2016
BD Divests Vertebral Augmentation Solutions Business to StrykerFRANKLIN LAKES, N.J., April 21, 2016 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®, AVAflex®, AVAtex® and AVAprep® branded products to Stryker.
This sale will not have a material impact to revenue and earnings for fiscal 2016. Financial and contractual terms of the transaction were not disclosed.
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, optimize respiratory care and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has more than 45,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit www.bd.com.
Source: Becton, Dickinson
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.